Weiss E I, London J, Kolenbrander P E, Kagermeier A S, Andersen R N
Infect Immun. 1987 May;55(5):1198-202. doi: 10.1128/iai.55.5.1198-1202.1987.
The interactions between Capnocytophaga ochracea ATCC 33596 and Streptococcus sanguis H1, Actinomyces naeslundii PK984, or Actinomyces israelii PK16 are dependent on specific recognitions between heat-sensitive adhesins on C. ochracea and heat-stable structures (probably carbohydrate-containing receptors) on the surfaces of these gram-positive coaggregation partners. The coaggregation of C. ochracea with each of these three organisms was inhibited by L-rhamnose and D-fucose and to a lesser extent by beta-methyl-galactoside. The reaction with S. sanguis was the most sensitive, while the coaggregation with A. israelii was the least sensitive and was only partially inhibited by each of the sugars that were considered to be effective inhibitors. A more effective inhibition of the coaggregation between C. ochracea and A. israelii was achieved by adding a combination of the 6-deoxysugars and N-acetylneuraminic acid. To further characterize the coaggregations, naturally occurring coaggregation-defective (Cog-) mutants of C. ochracea were obtained from several different selections. Three phenotypically distinct groups of mutants were were isolated. Type 1 mutants failed to coaggregate with S. sanguis only. Type 2 mutants lost ability to interact with both S. sanguis and A. naeslundii. Type 3 mutants failed to coaggregate with all three coaggregation partners. Characterization of the Cog- mutants by sugar inhibition studies made it possible to distinguish three classes of adhesin activity.
黄褐二氧化碳嗜纤维菌ATCC 33596与血链球菌H1、内氏放线菌PK984或衣氏放线菌PK16之间的相互作用取决于黄褐二氧化碳嗜纤维菌上热敏感黏附素与这些革兰氏阳性共聚伙伴表面热稳定结构(可能是含碳水化合物的受体)之间的特异性识别。L-鼠李糖和D-岩藻糖可抑制黄褐二氧化碳嗜纤维菌与这三种微生物中每一种的共聚,β-甲基半乳糖苷的抑制作用较小。与血链球菌的反应最敏感,而与衣氏放线菌的共聚最不敏感,且仅被认为是有效抑制剂的每种糖类部分抑制。通过添加6-脱氧糖和N-乙酰神经氨酸的组合,可更有效地抑制黄褐二氧化碳嗜纤维菌与衣氏放线菌之间的共聚。为了进一步表征共聚情况,从几个不同的筛选中获得了天然存在的黄褐二氧化碳嗜纤维菌共聚缺陷(Cog-)突变体。分离出了表型不同的三组突变体。1型突变体仅不能与血链球菌共聚。2型突变体失去了与血链球菌和内氏放线菌相互作用的能力。3型突变体不能与所有三个共聚伙伴共聚。通过糖抑制研究对Cog-突变体进行表征,从而有可能区分三类黏附素活性。